Unknown OBSERVATIONAL NCT05264285

Mitochondrial Health and Hemodynamic Instability Related to Renal Replacement Therapy in Critically Ill Patients (MitoHIRRT)

Exploring the Relationship Between Mitochondrial Health and Hemodynamic Instability Related to Renal Replacement Therapy in Critically Ill Patients

Sponsor: Ottawa Hospital Research Institute

Conditions Acute Kidney Injury (AKI)

Updated 5 times since 2022 Last updated: Sep 26, 2022 Started: Dec 6, 2021 Primary completion: Dec 1, 2023 Completion: Sep 30, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05264285, this observational or N/A phase trial focuses on Acute Kidney Injury (AKI) and remains ongoing. Sponsored by Ottawa Hospital Research Institute, it has been updated 5 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Nov 2024 — Present [monthly]

Unknown

Status: Recruiting → Unknown
Sep 2024 — Nov 2024 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Oct 2022 — Jul 2024 [monthly]

Recruiting
Apr 2022 — Oct 2022 [monthly]

Recruiting

First recorded

Dec 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ottawa Hospital Research Institute
University of Helsinki
University of Ottawa

Data source: Ottawa Hospital Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ottawa, Canada